Risk factors and prognosis for recurrent primary sclerosing cholangitis after liver transplantation: a Nordic Multicentre Study

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Scandinavian Journal of Gastroenterology

• Publication date

  2018-01-04

• Fields of study

  Medicine

• Identifiers
  DOI 10.1080/00365521.2017.1421705PMID 29301479
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Systematic review: recurrent autoimmune liver diseases after liver transplantation

  2017cited by this paper
• Patient Age, Sex, and Inflammatory Bowel Disease Phenotype Associate With Course of Primary Sclerosing Cholangitis.

  2017cited by this paper
• Biliary strictures and recurrence after liver transplantation for primary sclerosing cholangitis: A retrospective multicenter analysis

  2016cited by this paper
• Distinctive inflammatory bowel disease phenotype in primary sclerosing cholangitis.

  2015cited by this paper
• Risk factors for recurrent primary sclerosing cholangitis after liver transplantation.

  2015cited by this paper
• Immunosuppression after liver transplantation for primary sclerosing cholangitis influences activity of inflammatory bowel disease.

  2013influential reference
• Inflammatory bowel disease in patients with primary sclerosing cholangitis: Clinical characterization in liver transplanted and nontransplanted patients

  2012cited by this paper
• Recurrence and rejection in liver transplantation for primary sclerosing cholangitis.

  2012cited by this paper
• Risk Factors for Recurrence of Primary Sclerosing Cholangitis after Living Donor Liver Transplantation in Japanese Registry

  2011cited by this paper
• Cyclosporine A Protects Against Primary Biliary Cirrhosis Recurrence After Liver Transplantation

  2010cited by this paper
• Diagnosis and management of primary sclerosing cholangitis

  2010cited by this paper
• Risk Factors for Recurrence of Primary Sclerosing Cholangitis After Living Donor Liver Transplantation: A Single Center Experience

  2009cited by this paper
• A re‐evaluation of the risk factors for the recurrence of primary sclerosing cholangitis in liver allografts

  2009influential reference
• Risk factors for recurrence of primary sclerosing cholangitis after liver transplantation

  2008cited by this paper
• Recurrence of primary sclerosing cholangitis after living donor liver transplantation

  2007cited by this paper
• Cyclosporin versus tacrolimus for liver transplanted patients.

  2006cited by this paper
• Tacrolimus: a further update of its use in the management of organ transplantation.

  2003cited by this paper
• Different immunosuppressive regimens and recurrence of primary sclerosing cholangitis after liver transplantation

  2003cited by this paper
• Recurrence of primary sclerosing cholangitis following liver transplantation

  1999cited by this paper
• Recurrent primary sclerosing cholangitis after orthotopic liver transplantation: is chronic rejection part of the disease process?

  1998influential reference
• Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis.

  1996cited by this paper
• Recurrence of primary biliary cirrhosis in the liver allograft: the effect of immunosuppression.

  1996cited by this paper
• Relationship of Inflammatory Bowel Disease and Primary Sclerosing Cholangitis

  1991cited by this paper
• Primary sclerosing cholangitis: a review of its clinical features, cholangiography, and hepatic histology.

  1980cited by this paper

• Prospective, randomised, placebo-controlled, phase 2 clinical trial assessing the efficacy and safety of oral vancomycin in patients with primary sclerosing cholangitis with/out inflammatory bowel disease in Italy: study protocol of VanC-IT trial

  2026cites this paper
• Management of Inflammatory Bowel Disease Associated With Primary Sclerosing Cholangitis Pre- and Post-liver Transplantation.

  2026cites this paper
• Evaluation and Management of Primary Sclerosing Cholangitis Patients Awaiting Liver Transplantation

  2026cites this paper
• Development of the natural history component of an early economic model for primary sclerosing cholangitis

  2025cites this paper
• PSC-specific prognostic scores associated with graft loss and overall mortality in recurrent PSC after liver transplantation.

  2025cites this paper
• Geography-independent mucosal microbiota alterations in primary sclerosing cholangitis persist after liver transplantation

  2025cites this paper
• Recurrence of primary sclerosing cholangitis after liver transplantation: a French national cohort study including 571 patients.

  2025cites this paper
• Recurrence of Primary Sclerosing Cholangitis After Pediatric Liver Transplantation: A Single‐Center, Retrospective Study in Japan

  2025cites this paper
• Liver transplantation for cholestatic liver diseases: Timing & disease recurrence.

  2025cites this paper
• Recurrent and De Novo Liver Disease After Liver Transplantation.

  2025cites this paper
• PSC and colitis: A complex relationship.

  2025cites this paper
• Trends in liver transplantation for primary sclerosing cholangitis.

  2024cites this paper
• The mediating role of primary sclerosing cholangitis in the association between ulcerative colitis and hepatobiliary cancer investigated through Mendelian randomization

  2024cites this paper
• Outcome of Liver Retransplantation in Patients With Primary Sclerosing Cholangitis

  2024cites this paper
• Overexpression of TNFα in TNF∆ARE+/− mice increases hepatic periportal inflammation and alters bile acid signaling in mice

  2024cites this paper
• Medical treatment of primary sclerosing cholangitis: What have we learned and where are we going?

  2024cites this paper
• EASL Clinical Practice Guidelines on liver transplantation.

  2024cites this paper
• Recurrence of Primary Sclerosing Cholangitis and De Novo Cholangiocarcinoma After Liver Transplantation: Results From the Brazilian Cholestasis Consortium

  2024cites this paper
• Primary Sclerosing Cholangitis and Crohn's Disease: A Rare Association

  2024cites this paper
• S2k-Leitlinie Lebertransplantation der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft für Allgemein- und Viszeralchirurgie (DGAV)

  2024cites this paper
• Study of Risk Factors Associated With Recurrent Primary Sclerosing Cholangitis After Liver Transplantation in Shiraz >From 2011 to 2021.

  2024cites this paper
• Integrin αVß6 - autoantigen and driver of epithelial remodeling in colon and bile ducts in primary sclerosing cholangitis and inflammatory bowel disease.

  2024cites this paper
• Severe Cholestasis Predicts Recurrent Primary Sclerosing Cholangitis Following Liver Transplantation

  2024cites this paper
• Gut Microbiota in Primary Sclerosing Cholangitis: From Prognostic Role to Therapeutic Implications

  2024cites this paper
• A protective effect of inflammatory bowel disease on the severity of sclerosing cholangitis

  2024cites this paper
• Primary sclerosing cholangitis and the risks of posttransplant lymphoproliferative disorder.

  2024cites this paper
• Risk Factors for Recurrence of Primary Sclerosing Cholangitis after Liver Transplantation: Single-Center Data

  2024cites this paper
• Primary sclerosing cholangitis and inflammatory bowel disease: a complicated yet unique relationship.

  2024cites this paper
• Pediatric Cholestatic Diseases: Common and Unique Pathogenic Mechanisms.

  2024cites this paper
• Liver transplantation for primary sclerosing cholangitis—morbidities including disease recurrence

  2024cites this paper
• Intestinal Bacteremia After Liver Transplantation Is a Risk Factor for Recurrence of Primary Sclerosing Cholangitis

  2023cites this paper
• Microbial Players in Primary Sclerosing Cholangitis: Current Evidence and Concepts

  2023cites this paper
• Recurrent sclerosing cholangitis post-transplant: increased recurrence rates following re-transplantation

  2023cites this paper
• Inflammatory bowel disease and primary sclerosing cholangitis: One disease or two?

  2023cites this paper
• Liver Transplantation for Primary Sclerosing Cholangitis (PSC) With or Without Inflammatory Bowel Disease (IBD)—A European Society of Organ Transplantation (ESOT) Consensus Statement

  2023cites this paper
• Concurrent inflammatory bowel disease and primary sclerosing cholangitis: a review of pre- and post-transplant outcomes and treatment options

  2023cites this paper
• Cyclosporine vs. tacrolimus after liver transplantation for primary sclerosing cholangitis - a propensity-score matched intention-to-treat analysis.

  2023cites this paper
• Sclerosing cholangitis in children with inflammatory bowel disease

  2023cites this paper
• Colectomy in patients with ulcerative colitis is not associated to future diagnosis of primary sclerosing cholangitis

  2023cites this paper
• Post-Transplant Management and Complications of Autoimmune Hepatitis, Primary Biliary Cholangitis, and Primary Sclerosing Cholangitis including Disease Recurrence.

  2023cites this paper
• Inflammatory conditions play a role in recurrence of PSC after liver transplantation: An international multicentre study

  2022cites this paper
• Value of posttransplant protocol biopsies in 2 biliary autoimmune liver diseases

  2022cites this paper
• PSC associated inflammatory bowel disease: a distinct entity

  2022cites this paper
• FGF1 Signaling Modulates Biliary Injury and Liver Fibrosis in the Mdr2−/− Mouse Model of Primary Sclerosing Cholangitis

  2022cites this paper
• Post-Transplant Immunosuppression in Autoimmune Liver Disease.

  2022cites this paper
• A shared mucosal gut microbiota signature in primary sclerosing cholangitis before and after liver transplantation

  2022influential citation
• AASLD Practice Guidance on Primary Sclerosing Cholangitis and Cholangiocarcinoma.

  2022cites this paper
• The autophagic protein p62 is a target of reactive aldehydes in human and murine cholestatic liver disease

  2022cites this paper
• The clinical significance of biliary findings in magnetic resonance enterography of patients with inflammatory bowel disease

  2022cites this paper
• Donor age (≥45 years) and reduced immunosuppression are associated with the recurrent primary sclerosing cholangitis after liver transplantation – a multicenter retrospective study

  2021cites this paper
• Predicting Therapeutic Response in Pediatric Ulcerative Colitis—A Journey Towards Precision Medicine

  2021cites this paper
• Management of Autoimmune Liver Diseases after Liver Transplantation

  2021cites this paper
• Proceeding: Single Topic Conference in Autoimmune Liver Disease from the Canadian Association for the Study of the Liver

  2021cites this paper
• Recent advances in clinical practice: epidemiology of autoimmune liver diseases

  2021cites this paper
• Recurrent Primary Sclerosing Cholangitis: Current Understanding, Management, and Future Directions

  2021cites this paper
• IBD Diagnosis and Evaluation

  2021cites this paper
• Recurrence of primary sclerosing cholangitis after liver transplantation – analysing the European Liver Transplant Registry and beyond

  2021influential citation
• Recurrence of Primary Sclerosing Cholangitis After Liver Transplant in Children: An International Observational Study

  2021influential citation
• Causal Linkage Between Inflammatory Bowel Disease and Primary Sclerosing Cholangitis: A Two-Sample Mendelian Randomization Analysis

  2021cites this paper
• Recurrent Autoimmune Liver Disease and its Scientific Significance

  2020cites this paper
• Effects of Tumor Necrosis Factor Antagonists in Patients With Primary Sclerosing Cholangitis.

  2020cites this paper
• Management of primary sclerosing cholangitis and its complications: an algorithmic approach

  2020cites this paper
• Recent advances in the treatment of primary sclerosing cholangitis

  2020cites this paper
• Primär sklerosierende Cholangitis

  2020cites this paper
• Recurrence of primary sclerosing cholangitis after liver transplantation is associated with specific changes in the gut microbiome pretransplant – a pilot study

  2020cites this paper
• Impact of Preexisting Inflammatory Bowel Disease on the Outcome of Liver Transplantation for Primary Sclerosing Cholangitis

  2020influential citation
• Risk factors for recurrent autoimmune liver diseases after liver transplantation

  2020influential citation
• Recurrent Autoimmune Liver Disease and Its Impact on Clinical Practice

  2020cites this paper
• Does mucosal inflammation drive recurrence of primary sclerosing cholangitis in liver transplantion recipients with ulcerative colitis?

  2020cites this paper
• Systematic review with meta‐analysis: risk factors for recurrent primary sclerosing cholangitis after liver transplantation

  2019influential citation
• PSC-IBD: specific phenotype of inflammatory bowel disease associated with primary sclerosing cholangitis.

  2019cites this paper
• Recurrence of disease following organ transplantation in autoimmune liver disease and systemic lupus erythematosus.

  2019cites this paper
• Experience in Liver Transplantation Due to Primary Sclerosing Cholangitis: A Single Center Experience.

  2019cites this paper
• Precision Medicine in Liver Transplantation

  2019cites this paper
• Primary sclerosing cholangitis and inflammatory bowel disease: Intestine-liver interrelation.

  2019cites this paper
• Primary sclerosing cholangitis and inflammatory bowel disease: Intestine–liver interrelation

  2019cites this paper
• Extrahepatic autoimmunity in autoimmune liver disease.

  2019cites this paper
• Primary sclerosing cholangitis and inflammatory bowel disease comorbidity: an update of the evidence

  2019cites this paper
• Key roles of hepatologists in successful liver transplantation

  2018cites this paper
• Risk of recurrence of primary sclerosing cholangitis after liver transplantation is associated with de novo inflammatory bowel disease

  2018cites this paper
• Role of colectomy in preventing recurrent primary sclerosing cholangitis in liver transplant recipients.

  2018cites this paper
• The impact of ileal pouch‐anal anastomosis on graft survival following liver transplantation for primary sclerosing cholangitis

  2018cites this paper
• The IBD and PSC Phenotypes of PSC-IBD

  2018cites this paper
• Diagnosis, treatment and long-term outcome of autoimmune pancreatitis in Sweden.

  2018cites this paper
• Primary Sclerosing Cholangitis

  2016cites this paper
• Gastroenterología y Hepatología

  2016cites this paper
• Recurrent Disease After Liver Transplantation

  1998cites this paper